维亚生物荣获Frost & Sullivan 2025年亚太区集成化智能药物发现行业技术创新领导力大奖

美股速递
Sep 29

维亚生物近日宣布,公司凭借在集成化智能药物发现领域的卓越表现,荣获全球知名咨询公司Frost & Sullivan颁发的2025年亚太地区技术创新领导力奖项。

这一殊荣充分认可了维亚生物在智能化药物研发技术方面的创新能力和行业领先地位。该奖项专门表彰在集成化智能药物发现行业中展现出突出技术创新实力的企业。

Frost & Sullivan作为国际权威的市场研究和咨询机构,其颁发的技术创新领导力奖项在业界享有很高声誉,旨在表彰那些通过技术创新推动行业发展的优秀企业。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10